Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies and public health implications
Saverio Caini, Federica Bellerba, Federica Corso, Angélica Díaz-Basabe, Gioacchino Natoli, John Paget, Federica Facciotti, Sara Raimondi, Domenico Palli, Luca Mazzarella, Pier Giuseppe Pelicci, Paolo Vineis, Sara Gandini
doi: https://doi.org/10.1101/2020.05.03.20084160
Saverio Caini
1Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
Federica Bellerba
2Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy
Federica Corso
2Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy
Angélica Díaz-Basabe
2Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy
Gioacchino Natoli
2Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy
John Paget
3Netherlands Institute for Health Services Research (NIVEL), Utrecht, The Netherlands
Federica Facciotti
2Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy
Sara Raimondi
2Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy
Domenico Palli
1Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
Luca Mazzarella
2Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy
Pier Giuseppe Pelicci
2Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy
4Department of Hematology and Oncology, University of Milan, Milan, Italy
Paolo Vineis
5MRC Centre for Environment and Health, School of Public Health, Imperial College, London, United Kingdom
Sara Gandini
2Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy
Posted May 08, 2020.
Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies and public health implications
Saverio Caini, Federica Bellerba, Federica Corso, Angélica Díaz-Basabe, Gioacchino Natoli, John Paget, Federica Facciotti, Sara Raimondi, Domenico Palli, Luca Mazzarella, Pier Giuseppe Pelicci, Paolo Vineis, Sara Gandini
medRxiv 2020.05.03.20084160; doi: https://doi.org/10.1101/2020.05.03.20084160
Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies and public health implications
Saverio Caini, Federica Bellerba, Federica Corso, Angélica Díaz-Basabe, Gioacchino Natoli, John Paget, Federica Facciotti, Sara Raimondi, Domenico Palli, Luca Mazzarella, Pier Giuseppe Pelicci, Paolo Vineis, Sara Gandini
medRxiv 2020.05.03.20084160; doi: https://doi.org/10.1101/2020.05.03.20084160
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12562)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (463)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)